NCT06333028Not yet recruiting
A Study to Evaluate the enVista® Aspire (EA) Intraocular Lens in Subjects Undergoing Cataract Extraction
A Non-interventional, Prospective, Multicenter, Single Arm, Post-Marketing Clinical Study to Evaluate the enVista® Aspire (EA) Intraocular Lens in Subjects Undergoing Cataract Extraction.
Bausch & Lomb IncorporatedClinicalTrials.govdeviceDevice trial
Study focus
- Disease/Condition
- Cataract
- Drug/Device/Intervention
- enVista Aspire EA IOLs
- Study type
- Observational
- Intervention type
- device
Sponsor & location
- Primary sponsor
- Bausch & Lomb Incorporated
- Location
- Dover,Woodland Park,Garden City,Charleston,Sugar Land,Mount Pleasant, United States of America
Timeline & enrollment
- Phase
- N/A
- Start date
- Jun 01, 2024
- End date
- Sep 01, 2024
- Enrollment
- 100 participants
Primary outcome
Mean binocular BCDVA (logMAR) at Visit 1
Summary
A Study to Evaluate the enVista® Aspire (EA) intraocular lens in Subjects Undergoing Cataract
 Extraction
ICD-10 classifications
Other cataractCataract, unspecifiedComplicated cataractOther specified cataractSenile cataract
Data source
- Registry
- ClinicalTrials.gov
- Trial ID
- NCT06333028
- Type
- Device Trial
About this record
Access comprehensive clinical trial information for NCT06333028 through Pure Global AI's free database. This phase not specified trial is sponsored by Bausch & Lomb Incorporated and is currently Not yet recruiting. The study focuses on Cataract. Target enrollment is 100 participants.
This page provides complete trial specifications, intervention details, outcomes, and location information. Pure Global AI offers free access to ClinicalTrials.gov data, helping medical device and pharmaceutical companies navigate clinical research efficiently.